Utah Cash Conversion Cycle from 2010 to 2026
| UTMD Stock | USD 64.10 0.37 0.58% |
Cash Conversion Cycle | First Reported 2010-12-31 | Previous Quarter 170.8769414 | Current Value 107.41 | Quarterly Volatility 29.59711317 |
Check Utah Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Utah Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.5 M, Interest Expense of 675.3 K or Total Revenue of 37 M, as well as many indicators such as Price To Sales Ratio of 3.48, Dividend Yield of 0.0242 or PTB Ratio of 1.48. Utah financial statements analysis is a perfect complement when working with Utah Medical Valuation or Volatility modules.
Utah | Cash Conversion Cycle | Build AI portfolio with Utah Stock |
Analyzing Utah Medical's Cash Conversion Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Cash Conversion Cycle has evolved provides context for assessing Utah Medical's current valuation and future prospects.
Latest Utah Medical's Cash Conversion Cycle Growth Pattern
Below is the plot of the Cash Conversion Cycle of Utah Medical Products over the last few years. It is Utah Medical's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Utah Medical's overall financial position and show how it may be relating to other accounts over time.
| Cash Conversion Cycle | 10 Years Trend |
|
Cash Conversion Cycle |
| Timeline |
Utah Cash Conversion Cycle Regression Statistics
| Arithmetic Mean | 146.98 | |
| Geometric Mean | 144.30 | |
| Coefficient Of Variation | 20.14 | |
| Mean Deviation | 24.08 | |
| Median | 141.97 | |
| Standard Deviation | 29.60 | |
| Sample Variance | 875.99 | |
| Range | 109 | |
| R-Value | 0.46 | |
| Mean Square Error | 734.34 | |
| R-Squared | 0.21 | |
| Significance | 0.06 | |
| Slope | 2.71 | |
| Total Sum of Squares | 14,016 |
Utah Cash Conversion Cycle History
About Utah Medical Financial Statements
Utah Medical stakeholders use historical fundamental indicators, such as Utah Medical's Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Utah Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Utah Medical's assets and liabilities are reflected in the revenues and expenses on Utah Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Utah Medical Products. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Conversion Cycle | 170.88 | 107.41 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out the analysis of Utah Medical Correlation against competitors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Will Health Care Equipment & Supplies sector continue expanding? Could Utah diversify its offerings? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Utah Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.06) | Dividend Share 1.225 | Earnings Share 3.51 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
Utah Medical Products's market price often diverges from its book value, the accounting figure shown on Utah's balance sheet. Smart investors calculate Utah Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Utah Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.